Adrian R. Krainer

CIK: 0001780081

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

STOK

Stoke Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

STOK
Stoke Therapeutics, Inc.
Jun 3, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
17.8K shares-
STOK
Stoke Therapeutics, Inc.
Mar 10, 2026
Sale(S)
Direct
33.2K shares at avg. $39.74$1.3M
STOK
Stoke Therapeutics, Inc.
Mar 2, 2026
Sale(S)
Direct
7.2K shares at avg. $39.66$287K
STOK
Stoke Therapeutics, Inc.
Nov 24, 2025
Sale(S)
Direct
40.5K shares at avg. $29.72$1.2M
STOK
Stoke Therapeutics, Inc.
Nov 14, 2025
Sale(S)
Direct
19.8K shares at avg. $26.61$527K
STOK
Stoke Therapeutics, Inc.
Nov 14, 2025
Sale(S)
Direct
20.7K shares at avg. $27.34$565K
STOK
Stoke Therapeutics, Inc.
Jun 3, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
29.7K shares-

		Type	Shares	Price		Ownership
Jun 3, 2026	STOK Stoke Therapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	17,786	-	-	Direct
Mar 10, 2026	STOK Stoke Therapeutics, Inc.	Sale(S)	33,243	$39.74	$1,320,964	Direct
Mar 2, 2026	STOK Stoke Therapeutics, Inc.	Sale(S)	7,229	$39.66	$286,715	Direct
Nov 24, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	40,472	$29.72	$1,202,719	Direct
Nov 14, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	19,790	$26.61	$526,693	Direct
Nov 14, 2025	STOK Stoke Therapeutics, Inc.	Sale(S)	20,682	$27.34	$565,365	Direct
Jun 3, 2025	STOK Stoke Therapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	29,747	-	-	Direct

1-7 of 7 transactions

About Krainer Adrian R.

Krainer Adrian R. (SEC CIK 0001780081) files insider reports with the SEC as Director of Stoke Therapeutics, Inc. (STOK).

Signal8 holds 6 ownership filings by Krainer Adrian R., all Form 4s, filed between Jun 4, 2025 and Jun 5, 2026. Those filings report 7 transactions, from Jun 3, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Krainer Adrian R.'s filings is in BEDFORD, MA.

Recent filings by Krainer Adrian R.

Jun 3, 2026: Grant or award of STOK derivative securities (Form 4, code A).
Mar 10, 2026: Open-market sale of STOK shares (Form 4, code S).
Mar 2, 2026: Open-market sale of STOK shares (Form 4, code S).
Nov 24, 2025: Open-market sale of STOK shares (Form 4, code S).
Nov 14, 2025: Open-market sales of STOK shares (2 lines, Form 4, code S).

Other insiders filing for Stoke Therapeutics, Inc. (STOK)

Allan Jonathan, GENERAL COUNSEL & CORP SEC
Ticho Barry, CHIEF MEDICAL OFFICER
Cumbo Alexander, Director
Kaye Edward M. MD, Director
Harrison Seth Loring, Director
McCauley Thomas, Chief Scientific Officer

How to read Form 4 transaction codes